MARKET

CMMB

CMMB

Chemomab Therapeutics Ltd
NASDAQ
1.700
+0.030
+1.80%
After Hours: 1.740 +0.04 +2.35% 17:52 04/13 EDT
OPEN
1.650
PREV CLOSE
1.670
HIGH
1.730
LOW
1.650
VOLUME
20.68K
TURNOVER
--
52 WEEK HIGH
5.88
52 WEEK LOW
1.350
MARKET CAP
12.24M
P/E (TTM)
-1.2054
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CMMB last week (0406-0410)?
Weekly Report · 20h ago
Chemomab files Form 3 for CEO and director Adi Mor George beneficial ownership
Reuters · 3d ago
Chemomab Therapeutics director Neil Cohen files initial beneficial ownership statement
Reuters · 3d ago
Chemomab files Form 3 for CFO Fatal Sigal’s initial beneficial ownership stake
Reuters · 3d ago
Chemomab files Form 3 as director Alan Moses reports beneficial ownership
Reuters · 3d ago
Chemomab files Form 3 for Chief Development Officer John Lawler
Reuters · 3d ago
Weekly Report: what happened at CMMB last week (0330-0403)?
Weekly Report · 04/06 09:08
Chemomab files Form 3 for director Jill Quigley’s beneficial ownership statement
Reuters · 03/31 20:06
More
About CMMB
Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Webull offers Chemomab Therapeutics Ltd - ADR stock information, including NASDAQ: CMMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMMB stock methods without spending real money on the virtual paper trading platform.